Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of a polymethoxylated flavone, composition and preparation thereof for preventing or treating diabetes

A heptamethoxyflavone and diabetes technology, applied in the field of medicine, can solve the problems of neuropathy and diabetes pathology without substantial breakthrough, and achieve improvement of impaired glucose tolerance, improvement of fasting blood sugar level, and improvement of insulin sensitivity. reduced effect

Active Publication Date: 2019-03-15
GUANGZHOU MEDICAL UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, diet, exercise therapy, sulfonylureas, glinides, biguanides, thiazolidinediones, α-glucoside inhibitors, insulin, etc. are mainly used in the treatment of type II diabetes. There is no substantive breakthrough. While taking western medicine for a long time, patients continue to have complications such as cardiovascular disease, kidney disease, and neuropathy.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of a polymethoxylated flavone, composition and preparation thereof for preventing or treating diabetes
  • Use of a polymethoxylated flavone, composition and preparation thereof for preventing or treating diabetes
  • Use of a polymethoxylated flavone, composition and preparation thereof for preventing or treating diabetes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The technical solutions of the present invention will be described in detail below in conjunction with the accompanying drawings and embodiments.

[0021] experimental method:

[0022] 1. Establishment of animal models

[0023] Take 60 C57BL / 6 male mice, weighing 18-20 g, aged 6 weeks. After one week of adaptation, the mice were randomly divided into: normal chow diet (NCD), high fat diet (HFD), 3,5,6,7,8,3',4'-heptagram Low-dose oxyflavone group (HMF-L) and high-dose 3,5,6,7,8,3',4'-heptamethoxyflavone group (HMF-H), all groups except normal feed group Eat a high-fat diet. HFD feed formula is: 1.25% cholesterol, 20% lard, 5% sucrose, 0.5% cholic acid, vitamins adjusted to normal levels. Modeling began to administer drugs, and the experimental period was 6 weeks. NCD and HFD were given the same volume of 0.5% CMC-Na solution.

[0024] 2. Dosage and administration method: In the HFD induction experiment, mice were administered by intragastric administration. Modeli...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a polymethoxylated flavone, a composition and application of the polymethoxylated flavone preparation in preventing or treating diabetes. The active component of the medicine for preventing and treating diabetes comprises a polymethoxylated flavone and a pharmaceutically acceptable carrier or excipient which are made into a pharmaceutically acceptable preparation formulation, wherein the polymethoxylated flavone is 3,5,6,7,8,3',4'-heptamethoxyflavone. The invention proves that the 3,5,6,7,8,3',4'-heptamethoxyflavone can effectively improve the fasting blood glucose level increase of the high-fat-diet-induced diabetes model and improve the Type II diabetes mainly characterized in impaired glucose tolerance reduction and insulin sensitivity reduction, and thus, can be used for treating and preventing diabetes.

Description

technical field [0001] The invention belongs to the field of medicine and relates to new uses of natural products, in particular to the use of polymethoxylated flavones, compositions and preparations thereof for preventing or treating diabetes. Background technique [0002] Diabetes mellitus is an endocrine and metabolic disease characterized by hyperglycemia due to defective insulin secretion (type I diabetes) or insulin resistance (type II diabetes), and has now become the third major threat to human health after cardiovascular disease and cancer. disease. According to a report released by the International Diabetes Federation (IDF) in 2015, about 415 million adults worldwide suffer from diabetes, and about 5 million people are expected to die from diabetes. At present, diet, exercise therapy, sulfonylureas, glinides, biguanides, thiazolidinediones, α-glucoside inhibitors, insulin, etc. are mainly used in the treatment of type II diabetes. There is no substantive breakth...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/352A61K31/7048A61P3/10
CPCA61K31/352A61K31/7048A61K2300/00
Inventor 郑国栋刘鄂湖韦敏燕
Owner GUANGZHOU MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com